Showing results (1351-1360 of 2,774) with videos related to
Sort By:
Pageof 278
Bioanalysis|November 19, 2010
Biopharmaceutical Emerging Best Practices Association 2009C Jane RobinsonBioanalysis|July 14, 2026
Drawing a line in the sand: impact of analytical choices on anti-drug antibody cut-points and testing outcomesJoshua A Weiner, Linda A Banks, Harini Natarajan, et al.Bioanalysis|April 15, 2026
Vendor-specific HRP antibody conjugate differences lead to unexpected immunoassay reagent interactionsNancy Yu, Justin Low, Frank Macchi, et al.Bioanalysis|April 2, 2026
Examining pre-analytical factors for bioanalysis of protein therapeutics crossing the blood-brain barrier through receptor-mediated transcytosisWenyu Li, Jun Chen, Isha Taneja, et al.Bioanalysis|April 20, 2026
An update on the European Bioanalysis Forum recommendation on singlicate analysis for ligand binding assays: biomarker and anti-drug-antibody assaysMichael Wright, Richard Hughes, Gareth Satchell, et al.Bioanalysis|March 31, 2026
Biochemical characterization of cerebrospinal fluid in leptomeningeal carcinomatosis and infectious meningitis using the metabolic product model: a diagnostic performance evaluation in a single-center retrospective cohortXianglei Li, Yanna Ning, Jiaoyang Xu, et al.Bioanalysis|August 17, 2026
A validated bioanalytical LC-MS/MS method for the simultaneous determination of molnupiravir, N-hydroxycytidine, and baricitinib in human plasmaFatma H Ghazy, Ramzia I El-Bagary, Samar H Fahim, et al.Bioanalysis|August 11, 2026
Highlights from the 17th Japan Bioanalysis Forum SymposiumKatsutomo Hata, Naohito Yamada, Hiroyuki Shimizu, et al.Bioanalysis|August 18, 2026
From analytical similarity to clinical confidence: how regulatory evolution ensures comparable immunogenicity in streamlined biosimilar developmentSandra Ribes, Marc Rosenbaum, Laura Hartmann, et al.Bioanalysis|July 28, 2026
Dry chemistry-based approaches for point-of-care (POC) diagnosticsTanmayee Deshpande, Oyessi Dutta, Akshay Parmar, et al.Pageof 278